Green Thumb Industries (GTBIF) Profit After Tax (2019 - 2026)
Green Thumb Industries (GTBIF) posted Profit After Tax of $15.4 million for Q1 2026, down 81.49% on a QoQ basis from $83.2 million in Q4 2025, and up 85.37% year-over-year from $8.3 million in Q1 2025.
Green Thumb Industries (GTBIF) Profit After Tax (2019 - 2026) Analysis & Trends
Green Thumb Industries' Profit After Tax history runs 8 years deep, the most recent figure standing at $15.4 million for Q1 2026.
- Quarterly Profit After Tax rose 85.37% year-over-year to $15.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $121.2 million (up 140.98% YoY) and the FY2025 annual result came in at $114.2 million, up 54.57% from the prior year.
- Profit After Tax was $15.4 million for Q1 2026 at Green Thumb Industries, down from $83.2 million in the prior quarter.
- Across five years, Profit After Tax topped out at $83.2 million in Q4 2025 and bottomed at -$51.2 million in Q4 2022.
- A 5-year average of $14.8 million and a median of $12.7 million in 2024 frame the typical range for Profit After Tax.
- Annual changes were most pronounced in 2022 — Profit After Tax tumbled 324.62% — and 2025, when it soared 556.23%.
- Green Thumb Industries' Profit After Tax stood at -$51.2 million in 2022, then soared by 106.28% to $3.2 million in 2023, then surged by 294.25% to $12.7 million in 2024, then surged by 556.23% to $83.2 million in 2025, then plunged by 81.49% to $15.4 million in 2026.
- Business Quant data shows GTBIF's Profit After Tax at $15.4 million in Q1 2026, $83.2 million in Q4 2025, and $23.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | 369.00 Mn |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | 601.00 Mn |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | -2.35 Bn |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | 274.90 Mn |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | 176.40 Mn |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | 197.90 Mn |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | 57.00 Mn |
| 10 | Green Thumb Industries | 1.63 Bn | 1.29 Bn | 143.65 Mn | 15.40 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 15.40 Mn |
| Dec 31, 2025 | 83.20 Mn |
| Sep 30, 2025 | 23.29 Mn |
| Jun 30, 2025 | -645,000.00 |
| Mar 31, 2025 | 8.31 Mn |
| Dec 31, 2024 | 12.68 Mn |
| Sep 30, 2024 | 8.62 Mn |
| Jun 30, 2024 | 20.71 Mn |
| Mar 31, 2024 | 31.08 Mn |
| Dec 31, 2023 | 3.22 Mn |
| Sep 30, 2023 | 10.51 Mn |
| Jun 30, 2023 | 13.40 Mn |
| Mar 31, 2023 | 9.14 Mn |
| Dec 31, 2022 | -51.23 Mn |
| Sep 30, 2022 | 9.83 Mn |
| Jun 30, 2022 | 24.44 Mn |
| Mar 31, 2022 | 28.94 Mn |
| Dec 31, 2021 | 22.81 Mn |
| Sep 30, 2021 | 20.21 Mn |
| Jun 30, 2021 | 22.05 Mn |